The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, Tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
Semaglutide increases insulin release when blood sugar levels are elevated and decreases glucose production by the liver
(That study found no link to bad breath or dry mouth, though these symptoms may have been left out if they werent recorded by a diagnosis code.) Studies are limited with direct links to GLP-1s, Ouanounou said, but the mechanism, the pathways of the slow motility, leads to all these things, consistent with GI (gastrointestinal) physiology. Dry mouth might be a direct effect
10.1007/s11910-010-0104-8 Curr
The main clinic is in Tampa, and the program reaches patients in other areas as well